The Correlations among Depressive Symptoms, Cognitive Performance and Serum BDNF Levels in the Patients with Chronic Kidney Disease

키워드

참고문헌 (61)

1. Eggers PW, "Has the incidence of end-stage renal disease in the USA and other countries stabilized?", Curr Opin Nephrol Hypertens, 20, pp.241~245 (2011)[DOI]
2. McClellan AC, "Epidemiology, geography and chronic kidney disease", Curr Opin Nephrol Hypertens, 21, pp.323~328 (2012)[DOI]
3. Palmer S, "Prevalence of depression in chronic kidney disease: systematic review and meta-analysis of observational studies", Kidney Int, 84, pp.179~191 (2013)[DOI]
4. Ricardo AC, "Depressive symptoms and chronic kidney disease: results from the National Health and Nutrition Examination Survey (NHANES) 2005-2006", Int Urol Nephro, 42, pp.1063~1068 (2010)[DOI]
5. Link DK, "The right patient, the right treatment, the right access and the right time", Adv Chronic Kidney Dis, 21, pp.360~364 (2014)[DOI]
6. Hedayati SS, "Epidemiology, diagnosis, and management of depression in patients with CKD", Am J Kidney Dis, 54, pp.741~752 (2009)[DOI]
7. Wang PL, "Depression: a common but underrecognized condition associated with end-stage renal disease", Semin Dial, 17, pp.237~241 (2004)[DOI]
8. Cukor D, "Depression in endstage renal disease hemodialysis patients", Nat Clin Pract Nephrol, 2, pp.678~687 (2006)[DOI]
9. Krishnan V, "The molecular neurobiology of depression", Nature, 455, pp.894~902 (2008)[DOI]
10. Hashimoto K, "Brain-derived neurotrophic factor as a biomarker for mood disorders: an historical overview and future directions", Psychiatry Clin Neurosci, 64, pp.341~357 (2010)[DOI]
11. Hashimoto K, "Critical role of brain-derived neurotrophic factor in mood disorders", Brain Res Brain Res Rev, 45, pp.104~114 (2004)[DOI]
12. Duman RS, "A neurotrophic model for stress-related mood disorders", Biol Psychiatry, 59, pp.1116~1127 (2006)[DOI]
13. Castren E, "Neurotrophins in depression and antidepressant effects", Novartis Found Symp, 289, pp.43~52 (2008)
14. Numakawa T, "BDNF function and intracellular signaling in neurons", Histol Histopathol, 25, pp.237~258 (2010)
15. Yang ZF, "Identification of brain-derived neurotrophic factor as a novel functional protein in hepatocellular carcinoma", Cancer Res, 65, pp.219~225 (2005)
16. Schmidt HD, "The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior", Behav Pharmacol, 18, pp.391~418 (2007)[DOI]
17. Masi G, "The hippocampus, neurotrophic factors and depression: possible implications for the pharmacotherapy of depression", CNS Drugs, 25, pp.913~931 (2011)[DOI]
18. Karege F, "Decreased serum brain-derived neurotrophic factor levels in major depressed patients", Psychiatry Res, 109, pp.143~148 (2002)[DOI]
19. Yoshimura R, "Plasma levels of brain-derived neurotrophic factor and interleukin-6 in patients with dysthymic disorder: comparison with age- and sex-matched major depressed patients and healthy controls", Hum Psychopharmacol, 25, pp.566~569 (2010)[DOI]
20. Kanellopoulos D, "Hippocampal volumes and the brain-derived neurotrophic factor val66met polymorphism in geriatric major depression", Am J Geriatr Psychiatry, 19, pp.13~22 (2011)[DOI]
21. Frodl T, "Association of the brain-derived neurotrophic factor Val66Met polymorphism with reduced hippocampal volumes in major depression", Arch Gen Psychiatry, 64, pp.410~416 (2007)[DOI]
22. Harrisberger F, "BDNF Val66Met polymorphism and hippocampal volume in neuropsychiatric disorders: a systematic review and meta-analysis", Neurosci Biobehav Rev, 55, pp.107~118 (2015)[DOI]
23. Serra-Millas M, "Changes in plasma and platelet BDNF levels induced by S-citalopram in major depression", Psychopharmacology (Berl), 216, pp.1~8 (2011)[DOI]
24. Cattaneo A, "Reduced peripheral brain-derived neurotrophic factor mRNA levels are normalized by antidepressant treatment", Int J Neuropsychopharmacol, 13, pp.103~108 (2010)[DOI]
25. Etgen T, "Chronic kidney disease and cognitive impairment: a systematic review and meta-analysis", Am J Nephrol, 35, pp.474~482 (2012)[DOI]
26. Elias MF, "Kidney disease and cognitive function", Contrib Nephrol, 179, pp.42~57 (2013)
27. Sanchez-Roman S, "Neurocognitive profile of an adult sample with chronic kidney disease", J Int Neuropsychol Soc, 17, pp.80~90 (2011)[DOI]
28. Radic J, "The possible impact of dialysis modality on cognitive function in chronic dialysis patients", Neth J Med, 68, pp.153~157 (2010)
29. Bekinschtein P, "BDNF and memory processing", Neuropharmacology, 76, pp.677~683 (2014)[DOI]
30. Voineskos AN, "The brain-derived neurotrophic factor Val66Met polymorphism and prediction of neural risk for Alzheimer disease", Arch Gen Psychiatry, 68, pp.198~206 (2011)[DOI]
31. Montag C, "The BDNF Val-66Met polymorphism impacts parahippocampal and amygdala volume in healthy humans: incremental support for a genetic risk factor for depression", Psychol Med, 39, pp.1831~1839 (2009)[DOI]
32. Schofield PR, "Disturbances in selective information processing associated with the BDNF Val66Met polymorphism: evidence from cognition, the P300 and fronto-hippocampal systems", Biol Psychol, 80, pp.176~188 (2009)[DOI]
33. Blurton-Jones M, "Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease", Proc Natl Acad Sci U S A, 106, pp.13594~13599 (2009)[DOI]
34. Juhasz G, "The CREB1-BDNF-NTRK2 pathway in depression: multiple gene-cognition-environment interactions", Biol Psychiatry, 69, pp.762~771 (2011)[DOI]
35. Zoladz JA, "Hemodialysis decreases serum brain-derived neurotrophic factor concentration in humans", Neurochem Res, 37, pp.2715~2724 (2012)[DOI]
36. Levey AS, "Chronic kidney disease", Lancet, 379, pp.165~180 (2012)[DOI]
37. Levey AS, "National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification", Ann Intern Med, 139, pp.137~147 (2003)[DOI]
38. Levey AS, "The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report", Kidney Int, 80, pp.17~28 (2011)[DOI]
39. Hahn H, "A standardization study of Beck Depression Inventory in Korea", J Korean Neuropsychiatr Assoc, 25, pp.487~500 (1986)
40. 이중서, "한국판 Hamilton 우울증 평가 척도의 신뢰도, 타당도 연구", 신경정신의학, 44(4), pp.456~465 (2005), 대한신경정신의학회
41. Kuslansky G, "Detecting dementia with the Hopkins Verbal Learning Test and the Mini-Mental State Examination", Arch Clin Neuropsychol, 19, pp.89~104 (2004)[DOI]
42. Lacy M, "Standardized mini-mental state examination scores and verbal memory performance at a memory center: implications for cognitive screening", Am J Alzheimers Dis Other Demen, 30, pp.145~152 (2015)[DOI]
43. Xu X, "Risk Factors for Possible Dementia Using the Hopkins Verbal Learning Test and the Mini-Mental State Examination in Shanghai", Diagnostics (Basel), 5, pp.487~496 (2015)[DOI]
44. Lee JH, "Development of the Korean version of the Consortium to Establish a Registry for Alzheimer's Disease Assessment Packet (CERAD-K): clinical and neuropsychological assessment batteries", J Gerontol B Psychol Sci Soc Sci, 57, pp.47~53 (2002)[DOI]
45. Baek MJ, "The usefulness of the story recall test in patients with mild cognitive impairment and Alzheimer's disease", Neuropsychol Dev Cogn B Aging Neuropsychol Cogn, 18, pp.214~229 (2011)[DOI]
46. 이정구, "Decreased Serum Brain-Derived Neurotrophic Factor Levels in Elderly Korean with Dementia", PSYCHIATRY INVESTIGATION, 6(4), pp.299~305 (2009), 대한신경정신의학회
47. Tossani E, "Depression and renal disease", Semin Dial, 18, pp.73~81 (2005)
48. Kimmel PL, "Depression in patients with chronic renal disease: what we know and what we need to know", J Psychosom Res, 53, pp.951~956 (2002)[DOI]
49. Hedayati SS, "The predictive value of self-report scales compared with physician diagnosis of depression in hemodialysis patients", Kidney Int, 69, pp.1662~1668 (2006)[DOI]
50. Nuevo R, "Usefulness of the Beck Depression Inventory as a screening method for depression among the general population of Finland", Scand J Public Health, 37, pp.28~34 (2009)
51. Satthapisit S, "The comparison of Montgomery and Asberg Depression Rating Scale (MADRS thai) to diagnostic and statistical manual of mental disorders (DSM) and to Hamilton Rating Scale for Depression (HRSD): validity and reliability", J Med Assoc Thai, 90, pp.524~531 (2007)
52. Nestler EJ, "Neurobiology of depression", Neuron, 34, pp.13~25 (2002)[DOI]
53. Drevets WC, "Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders", Curr Opin Neurobiol, 11, pp.240~249 (2001)[DOI]
54. Kempermann G, "The neurogenic reserve hypothesis: what is adult hippocampal neurogenesis good for?", Trends Neurosci, 31, pp.163~169 (2008)[DOI]
55. Marchelek-Mysliwiec M, "Insulin resistance and brain-derived neurotrophic factor levels in chronic kidney disease", Ann Clin Biochem, 52, pp.213~219 (2015)[DOI]
56. Kielstein H, "Role of the endogenous nitric oxide inhibitor asymmetric dimethylarginine (ADMA) and brain-derived neurotrophic factor (BDNF) in depression and behavioural changes: clinical and preclinical data in chronic kidney disease", Nephrol Dial Transplant, 30, pp.1699~1705 (2015)[DOI]
57. Meuwese CL, "Chronic kidney disease and hypothalamic-pituitary axis dysfunction: the chicken or the egg?", Arch Med Res, 44, pp.591~600 (2013)[DOI]
58. Watanabe K, "Cerebro-renal interactions: impact of uremic toxins on cognitive function", Neurotoxicology, 44, pp.184~193 (2014)[DOI]
59. Umemura T, "Association of chronic kidney disease and cerebral small vessel disease with cognitive impairment in elderly patients with type 2 diabetes", Dement Geriatr Cogn Dis Extra, 3, pp.212~222 (2013)[DOI]
60. McIntyre RS, "Cognition in major depressive disorder: a 'Systemically Important Functional Index' (SIFI)", Curr Opin Psychiatry, 29, pp.48~55 (2016)[DOI]
61. MacQueen GM, "Cognitive dysfunction in major depression and bipolar disorder: assessment and treatment options", Psychiatry Clin Neurosci, 71, pp.18~27 (2017)[DOI]

관련 논문AI추천